Is Trevi Therapeutics Inc (TRVI) Stock at the Top of the Biotechnology Industry?

A rating of 100 puts Trevi Therapeutics Inc (TRVI) near the top of the Biotechnology industry according to InvestorsObserver. Trevi Therapeutics Inc's score of 100 means it scores higher than 100% of stocks in the industry. Trevi Therapeutics Inc also received an overall rating of 93, putting it above 93% of all stocks. Biotechnology is ranked 66 out of the 148 industries.

TRVI has an Overall Score of 93. Find out what this means to you and get the rest of the rankings on TRVI!

See Full TRVI Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Trevi Therapeutics Inc Stock Today?

Trevi Therapeutics Inc (TRVI) stock has gained 4.48% while the S&P 500 has fallen -1.29% as of 3:22 PM on Monday, Apr 11. TRVI is higher by $0.12 from the previous closing price of $2.68 on volume of 2,130,088 shares. Over the past year the S&P 500 is up 7.32% while TRVI is higher by 3.70%. TRVI lost -$1.49 per share the over the last 12 months. Click Here to get the full Stock Report for Trevi Therapeutics Inc stock.